Patents by Inventor Andre Thomas Baron

Andre Thomas Baron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKERS FOR OVARIAN CANCER
    Publication number: 20250237655
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease or other malignant condition. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: August 5, 2024
    Publication date: July 24, 2025
    Applicants: ASPIRA WOMEN'S HEALTH INC., THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
    Inventors: ERIC THOMAS FUNG, FREDERICK RAND UELAND, J.R. VAN NAGELL, PAUL DUANE DEPRIEST, ANDRE THOMAS BARON
  • BIOMARKERS FOR OVARIAN CANCER
    Publication number: 20170089906
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that am useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease or other malignant condition. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: November 30, 2016
    Publication date: March 30, 2017
    Applicants: VERMILLION, INC., THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
    Inventors: ERIC THOMAS FUNG, FREDERICK RAND UELAND, J.R. VAN NAGELL, PAUL DUANE DEPRIEST, ANDRE THOMAS BARON
  • BIOMARKERS FOR OVARIAN CANCER
    Publication number: 20140038899
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease or other malignant condition. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: June 12, 2013
    Publication date: February 6, 2014
    Applicants: The University of Kentucky Research Foundation, Vermillion, Inc.
    Inventors: Eric Thomas Fung, Frederick Rand Ueland, Van Nagell, JR., Paul Duane Depriest, Andre Thomas Baron
  • BIOMARKERS FOR OVARIAN CANCER
    Publication number: 20100105067
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease or other malignant condition. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: June 23, 2006
    Publication date: April 29, 2010
    Applicants: CIPHERGEN BIOSYSTMES, INC., UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
    Inventors: Eric Thomas Fung, Frederick Rand Ueland, J.R. van Nagell, Paul Duane Depriest, Andre Thomas Baron